2_logs_higher Posted - 18 hours ago

$AGEN Dr Kasi on the Potential Implications of ctDNA presence in Colorectal Cancer https://www.onclive.com/view/dr-kasi-on-the-potential-implications-of-ctdna-presence-in-colorectal-cancer

2_logs_higher Posted - 18 hours ago

$AGEN The AACR Releases a Call to Action and Key Statistics in Cancer Disparities Progress Report 2024 https://www.onclive.com/view/the-aacr-releases-a-call-to-action-and-key-statistics-in-cancer-disparities-progress-report-2024

Scooter0732 Posted - 20 hours ago

$AGEN you get G coins on the 10th of each month if you hold shares. Dude do a little DD for heavens sake, it’s all in the prospectus w/ the SEC

pcooper88 Posted - 20 hours ago

$AGEN hi guys does this stock have monthly dividends. Thank u

ElectricJ Posted - 1 day ago

$AGEN

Bmcgoo Posted - 1 day ago

$AGEN I keep wondering about Bal/Zal in China with Betta. Anyone know anything, there ??

docBNM Posted - 1 day ago

$AGEN somebody at Goldman likes it ….

Brianrudi_ Posted - 2 days ago

$AGEN what a massive, infectious pile of waste. Garo has got to GO!

Capitulation_0 Posted - 2 days ago

$AGEN 100m financing by $LGND Big hedge funds. $30 pre-R/S. FDA type B. Everything is lining up.

Green_Johnnie Posted - 2 days ago

$AGEN volume is very low.

Capitulation_0 Posted - 2 days ago

$AGEN point 72, deep track, GS are notable investors here.. Point and GS added recently.

Bmcgoo Posted - 2 days ago

$AGEN Lookin' good. RSI looks great. RSI has been a good indicator.

Capitulation_0 Posted - 2 days ago

$AGEN point 72 is deep in this... Type B meeting with FDA. Should be in the 30's if you factor in RS

Zenlama Posted - 2 days ago

$AGEN Wait for it

StockTech7 Posted - 2 days ago

$AGEN what's Garo's plan now. Does he think the stock price is actually going to go up on data and BLA so he can squeeze more money out of shareholders again or is some partner waiting for the BLA to come in and save the day. Wouldn't be surprised if he screws it up for shareholders again. 😬

Framework Posted - 2 days ago

$AGEN Bot Bal Gov FDA /Pause https://finance.yahoo.com/news/fda-grants-agenus-type-b-113000961.html

manny11419 Posted - 2 days ago

$AGEN I wonder if the high risk registration strategy cause Todd Yancey to leave..the shorts were correct on Bal/zal failure...it takes guts to short biotech stocks..and they've been right for the past few years. on the Nov. CC ...midyear BLA have been mentioned four times...sometimes. Sometimes the new guys don't want to be associated with optimistic languages..Gupta left in a hurry also.

docBNM Posted - 2 days ago

$AGEN Owner Name Date Shares Held Change (Shares) Change (%) Value (In 1,000s) Goldman Sachs Group Inc 3/31/2024 3,285,071 3,140,390 2170.561% $35,413

MoneyTalksStocksWalk Posted - 3 days ago

@OracleofOntario @Disney1295 I’m bullish on $AGEN as well, don’t get me wrong. But, I also know that a majority of investors and traders in the biotech world are abnormally impatient when it comes to biotech companies so majority of them exit then return at usually a cheaper position before the cascade of a catalyst occurs. I had many positions in AGEN and most recently sold at 13.03- I will re-enter in the $8-9$ range and wait - the probability of their BLA being accepted is probably 90% - considering most other treatments are entirely useless

Carl_K Posted - 3 days ago

$AGEN $INTS may be one to look into. "Data from that same trial presented at CTOS in November 2023 and ASCO 2023 in June 2023 showed a disease control rate of 93% for subjects on INT230-6 alone, and median overall survival of 21.5 months. Disease control rate measures the percentage of patients who have achieved stable disease, partial response or complete response. In comparison, Agenus' (AGEN) combination therapy of immune-activating botensilimab and anti-PD-1 checkpoint inhibitor balstilimab, looked at as a very interesting drug candidate for a multitude of solid tumors, has a disease control rate of 63% in a Phase 1b trial, with a median of three prior lines of therapy. INT230-6's 93% disease control rate is well above that, for the same indication." https://seekingalpha.com/article/4693038-intensity-therapeutics-a-bargain-for-a-late-stage-company-with-a-remarkable-oncology-drug

MITornado Posted - 3 days ago

$AGEN

OracleofOntario Posted - 3 days ago

$AGEN every time the company releases positive news the shorts pile on to keep the price from running - let's see how long they can keep that up.

docBNM Posted - 3 days ago

$AGEN has there been any new fund/index purchases since the reverse split ? that's what it was for besides Naz listing !!!!

Gmanthemagnificent Posted - 3 days ago

$AGEN this smells like the zal/ bal debacle all over again... stay tuned!

Scooter0732 Posted - 3 days ago

$AGEN Expected selloff on news that was known already to the market. I am happy to be invested here, and wait for when the company is ready to file a BLA because, quite simply, they are doing very important work. If you're in for the ride then this means nothing.

MITornado Posted - 3 days ago

$AGEN $15 January 2024 options selling for $2.50. Selling here is ridiculous.

weichsel1 Posted - 3 days ago

$AGEN Wacky. About 11.20 in pre-market trading. now 10.22. Down .56. All on good news from the FDA on approval process. Any explanation?